UBC PiMS Research Group
Pharmacoepidemiology in Multiple Sclerosis Research Group

Lay Summary

Association between anti-depressants drugs on the progression of multiple sclerosis.

Researchers found no evidence to suggest that exposure to the antidepressants ‘selective serotonin reuptake inhibitors’ were associated with a delay in MS disability accumulation or progression.

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada
Email:

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia